Avalo Therapeutics (AVTX) Change in Account Payables (2014 - 2026)
Avalo Therapeutics posted quarterly Change in Account Payables of $219000.0 for Q1 2026, down 44.97% year-on-year from $398000.0 in Q1 2025, and up 164.99% on a QoQ basis from -$337000.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Change in Account Payables data on file, last reported at $219000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 44.97% year-over-year to $219000.0; the trailing twelve-month figure through Mar 2026 stood at -$325000.0 (down 38.3% YoY), and the FY2025 full-year result was -$146000.0, up 10.43% from the prior year.
- Change in Account Payables for Q1 2026 stood at $219000.0, up from -$337000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.7 million in Q1 2023 and bottomed at -$4.8 million in Q2 2023.
- The 5-year median for Change in Account Payables is $37000.0 (2023), against an average of -$177235.3.
- Peak annual rise in Change in Account Payables reached 3027.03% in 2024, while the deepest fall reached 346.78% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $1.4 million in 2022, then tumbled by 123.83% to -$342000.0 in 2023, then slumped by 346.78% to -$1.5 million in 2024, then jumped by 77.95% to -$337000.0 in 2025, then jumped by 164.99% to $219000.0 in 2026.
- The last three Change in Account Payables figures came in at $219000.0 (Q1 2026), -$337000.0 (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 219,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 219,000.00 |
| Mar 31, 2026 | 219,000.00 |
| Dec 31, 2025 | -337,000.00 |
| Dec 31, 2025 | -337,000.00 |
| Sep 30, 2025 | -1.89 Mn |
| Sep 30, 2025 | -1.89 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 398,000.00 |
| Mar 31, 2025 | 398,000.00 |
| Dec 31, 2024 | -1.53 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | -262,000.00 |
| Jun 30, 2024 | -262,000.00 |
| Mar 31, 2024 | 470,000.00 |
| Mar 31, 2024 | 470,000.00 |
| Dec 31, 2023 | -342,000.00 |
| Dec 31, 2023 | -342,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | -4.81 Mn |
| Jun 30, 2023 | -4.81 Mn |
| Mar 31, 2023 | 2.68 Mn |
| Mar 31, 2023 | 2.68 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | -717,000.00 |
| Sep 30, 2022 | -717,000.00 |
| Jun 30, 2022 | -1.59 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | 388,000.00 |
| Mar 31, 2022 | 388,000.00 |
| Dec 31, 2021 | -198,000.00 |
| Dec 31, 2021 | -198,000.00 |
| Sep 30, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | -9.66 Mn |
| Jun 30, 2021 | -9.66 Mn |
| Mar 31, 2021 | 9.34 Mn |
| Mar 31, 2021 | 9.34 Mn |
| Dec 31, 2020 | 647,000.00 |
| Dec 31, 2020 | 647,000.00 |
| Sep 30, 2020 | -631,000.00 |
| Sep 30, 2020 | -631,000.00 |
| Jun 30, 2020 | -168,000.00 |
| Jun 30, 2020 | -168,000.00 |
| Mar 31, 2020 | 251,000.00 |
| Mar 31, 2020 | 251,000.00 |
| Dec 31, 2019 | 1.64 Mn |
| Dec 31, 2019 | 1.64 Mn |
| Sep 30, 2019 | -619,003.00 |
| Sep 30, 2019 | -619,003.00 |
| Jun 30, 2019 | 196,005.00 |
| Jun 30, 2019 | 196,005.00 |
| Mar 31, 2019 | -196,671.00 |
| Mar 31, 2019 | -196,671.00 |
| Dec 31, 2018 | -89,792.00 |
| Dec 31, 2018 | -89,792.00 |
| Sep 30, 2018 | -1.47 Mn |
| Sep 30, 2018 | -1.47 Mn |
| Jun 30, 2018 | -226,001.00 |
| Jun 30, 2018 | -226,001.00 |
| Mar 31, 2018 | 1.87 Mn |
| Mar 31, 2018 | 1.87 Mn |
| Dec 31, 2017 | 793,760.00 |
| Dec 31, 2017 | 793,760.00 |
| Sep 30, 2017 | -14,788.00 |
| Sep 30, 2017 | -14,788.00 |
| Jun 30, 2017 | -268,574.00 |
| Jun 30, 2017 | -268,574.00 |
| Mar 31, 2017 | -414,333.00 |
| Mar 31, 2017 | -414,333.00 |
| Dec 31, 2016 | 222,192.00 |
| Dec 31, 2016 | 222,192.00 |
| Sep 30, 2016 | 48,715.00 |
| Sep 30, 2016 | 48,715.00 |
| Jun 30, 2016 | 132,591.00 |
| Jun 30, 2016 | 132,591.00 |
| Mar 31, 2016 | -71,398.00 |
| Mar 31, 2016 | -71,398.00 |
| Dec 31, 2015 | -586,927.00 |
| Dec 31, 2015 | -586,927.00 |
| Sep 30, 2015 | 321,696.00 |
| Sep 30, 2015 | 321,696.00 |
| Jun 30, 2015 | 205,606.00 |
| Jun 30, 2015 | 205,606.00 |
| Mar 31, 2015 | -209,084.00 |
| Mar 31, 2015 | -209,084.00 |
| Dec 31, 2014 | -386,865.00 |
| Dec 31, 2014 | -386,865.00 |